Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04547062
Title Monocentric Phase 1 Study With Escalation of Doses of Tocilizumab in Combination With Chemotherapy (Idarubicin and Cytarabine) in Patients With Acute Myeloblastic Leukemia (AML) (Tocilam)
Acronym Tocilam
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nantes University Hospital
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.